Oxford Biosystems

  • News

    News from Oxford BioSystems

    News from Oxford BioSystems
Archive by category: NeurologyReturn
Using blood biomarkers to study the link between Alzheimer’s disease and Obesity
24Feb

Using blood biomarkers to study the link between Alzheimer’s disease and Obesity

Oxford Biosystems | 24 Feb, 2026 | Neurology |
Biomedical Scientist recently published ‘A preventative approach for Alzheimer’s’, which explores the first study evaluating the impact of obesity on Alzheimer’s blood biomarkers.
Read More
The Value of soluble Interleukin-2 Receptor (sIl-2R) as a Diagnostic and Predictive Biomarker
03Feb

The Value of soluble Interleukin-2 Receptor (sIl-2R) as a Diagnostic and Predictive Biomarker

Oxford Biosystems | 03 Feb, 2026 | Immunology, Neurology, Oncology |
The interleukin-2 receptor (IL-2R), also known as CD25, is a transmembrane protein, which is up-regulated on activated T-cells, and shed into serum as soluble IL-2R...
Read More

Categories

Oxford BioSystems

184B Park Drive Milton Park Abingdon Oxon OX14 4SE

Oxford Biosystems has pledged to be an Antibiotic Guardian

members of

BIVDA Member Logo IBMS Company Member